Boston Scientific Corporation
MX ˙ BMV ˙ FR0010424135
SecurityMX:BSX / Boston Scientific Corporation
InstitutionCatalyst Financial Partners Llc
Latest Disclosed Ownership8,538 shares
Latest Disclosed Value $ 535,760
Catalyst Financial Partners Llc reports 9.92% decrease in ownership of BSX / Boston Scientific Corporation

On May 11, 2026 - Catalyst Financial Partners Llc filed a 13F-HR form disclosing ownership of 8,538 shares of Boston Scientific Corporation (MX:BSX) valued at $535,760 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 9,478 shares of Boston Scientific Corporation. This represents a change in shares of -9.92% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BOSTON SCIENTIFIC COM 101137107 8,538 -940 -9.92 536 -40.75 0.0633
2026-02-04 2025-12-31 13F BOSTON SCIENTIFIC COM 101137107 9,478 1,305 15.97 904 13.30 0.1008
2025-11-12 2025-09-30 13F BOSTON SCIENTIFIC COM 101137107 8,173 182 2.28 798 -7.11 0.0962
2025-08-14 2025-06-30 13F BOSTON SCIENTIFIC COM 101137107 7,991 -78 -0.97 858 5.41 0.0937
2025-05-02 2025-03-31 13F BOSTON SCIENTIFIC COM 101137107 8,069 942 13.22 814 27.99 0.1498
2025-01-30 2024-12-31 13F BOSTON SCIENTIFIC COM 101137107 7,127 154 2.21 637 8.90 0.1197
2024-10-28 2024-09-30 13F BOSTON SCIENTIFIC COM 101137107 6,973 -62 -0.88 584 7.95 0.1143
2024-07-25 2024-06-30 13F BOSTON SCIENTIFIC COM 101137107 7,035 738 11.72 542 26.70 0.1190
2024-04-23 2024-03-31 13F BOSTON SCIENTIFIC COM 101137107 6,297 683 12.17 428 31.79 0.1101
2024-02-07 2023-12-31 13F BOSTON SCIENTIFIC COM 101137107 5,614 270 5.05 325 14.89 0.0916
2023-10-26 2023-09-30 13F BOSTON SCIENTIFIC COM 101137107 5,344 307 6.09 282 3.68 0.0910
2023-08-02 2023-06-30 13F BOSTON SCIENTIFIC COM 101137107 5,037 57 1.14 272 9.24 0.0971
2023-04-11 2023-03-31 13F BOSTON SCIENTIFIC COM 101137107 4,980 -80 -1.58 249 6.41 0.1067
2023-01-19 2022-12-31 13F BOSTON SCIENTIFIC COM 101137107 5,060 5,060 234 0.1204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.